PolyPeptide soars after wins 100-million-euro annual deal

PolyPeptide AG

19/12/2022 07:36

** PolyPeptide  PPGN.S  shares skyrocket around 15% after
the Swiss group said it has signed a deal worth around 100
million euros ($106.36 million) annually starting in 2024
    ** The firm, which makes peptides for pharma and biotech
companies, said the deal was for one of its phase III custom
projects
    ** PolyPeptide's shares top Switzerland's midcaps index
 .SMII  in Julius Baer pre-market trade
($1 = 0.9402 euros)
 (Reporting by Tristan Chabba)
 ((Tristan.chabba@thomsonreuters.com))